Delivery Order SPE2DB22D7065-SPE2DB24FH2CB

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, to provide AIMOVIG 140 mg/mL autoinjectors. The $1,357.86 firm-fixed-price contract has a completion date of July 10, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a broad range of pharmaceutical products and medical supplies to DLA...
The U.S. government, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $3,134.10 Firm Fixed Price Delivery Order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999.00 through December 31, 2025, which enables the DLA to efficiently procure a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a $2,461.44 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIMOVIG 70 MG/ML AUTOINJECTOR, a specialty medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a $1,796.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AIMOVIG 70 mg/ml autoinjectors. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,895.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, with a completion date of February 1, 2024. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp,...
The U.S. Defense Logistics Agency (DLA) awarded a $8,761.90 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of AIMOVIG 70 MG/ML autoinjectors, with a period of performance ending on August 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which allows the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $10,901.62 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. This order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999.00, awarded to Amerisourcebergen by the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded a $3,125.09 firm-fixed price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML autoinjectors. The order has an ultimate completion date of August 23, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for providing a comprehensive range of medical commodities to support military treatment programs and...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AIMOVIG 70 MG/ML AUTOINJECTOR medication. The $5,540.10 contract has a performance period through March 15, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,264.14 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
  • SPE2DB22D7065
    Indefinite Delivery Contract
  • SPE2DB22D7065-SPE2DB24FH2CB
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $3,615.28 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the provision of AIMOVIG 70 MG/ML AUTOINJECTORML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the U.S. Department of Defense globally. The contract does not have a set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market. Additionally, Amerisourcebergen holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 10/1/24, 12:57 PM